 Efficacy safety aztreonam treatment patients renal failure efficacy safety aztreonam treatment gram-negative bacterial infections patients renal failure open study Thirty-nine patients years old renal failure chronic acute severe gram-negative bacterial infections gram-negative pathogens sensitive pathogens Escherichia coli Pseudomonas aeruginosa Klebsiella species Proteus species Enterobacter species Serratia Acinetobacter species Complete cure clinical bacteriologic infections improvement clinical improvement bacteriologic cure Bacterial eradication infecting pathogens significant adverse effect slight transient elevation level serum transaminases patients Renal function patients treatment Levels serum creatinine mg/dL treatment aztreonam effective safe treatment gram-negative bacterial infections patients renal failure